跳至主要内容
临床试验/CTRI/2022/09/045671
CTRI/2022/09/045671尚未招募不适用

Clinical Study Of Recurrent Urinary tract infection( Tadiya Majari e Bol Mutwatir) and its management with unani medicines.

PG Dept of Moalejat General Medicine1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2022年9月20日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
40
试验地点
1
主要终点
Depends on before and after treatment.

研究概览

简要总结

In Recurrent Urinary tract infection (Rutis) usual prophylactic antibiotics regimens donot change the long term risk of occurrence.the aim of the study is to evaluate the efficacy of unani medicines in Rutis.In this Randomised Single arm study with a sample size of 40 patients and 6 weeks of treatment with some inclusion and exclusion criteria( mentioned in part 6).

The study will be conducted.

研究设计

研究类型
Interventional
分配方式
Coin toss, Lottery, toss of dice, shuffling cards etc
盲法
Participant Blinded

入排标准

年龄范围
18.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • 1.Recurrent uti with positive urine culture, 2.Patients with symptoms as follows a.Burning micturition b.Urgency, c.frequency of micturition d.Haematuria(Benign) e.Lower abdominal pain/supra pubic pain f.Fever with chills and rigor g.Nausea and vomitings 3.Patients with renal calculi.

排除标准

  • 1.Complicated UTI 2.Patients with pregnancy 3.Patients with BPH 4.Chronic infections like TB; Gonorrhea; Syphills 5.Diabetes Mellitus 6.Patients with congenital abnormalities like polycystic kidney; renal agenesis; renal hypoplasia ; uretrovesical junction obstruction.

结局指标

主要结局

Depends on before and after treatment.

时间窗: Cure of the disease,relief in symptoms

Treatment will be given for the duration of 6 weeks

时间窗: Cure of the disease,relief in symptoms

次要结局

  • Depends on before and after treatment(1.Changes in urine culture and sensitivity i.e negative culture 2.Cure of the disease, relief in symptoms)

研究者

发起方
PG Dept of Moalejat General Medicine
申办方类型
Research institution and hospital

研究点 (1)

Loading locations...

相似试验